Some factors influencing the anticoagulant action of heparin.

نویسندگان

  • L B Jaques
  • R A Mustard
چکیده

IT has been generally assumed that the anticoagulant action of heparin is due to direct combination with prothrombin, thrombin, or kinase. The chief experimental facts on this point have been confirmed by Mustard & Jaques [1937] and may be summarized as follows. When citrated plasma and thrombin are used to test the action of heparin, the heparin acts as an antithrombin [Howell, 1925]. When kinase is added, it neutralizes the action of heparin. It is thus possible to "titrate " heparin against kinase [Fischer & Astrup, 1935]. If the prothrombin is removed from the plasma with alumina gel, the heparin is still active but the corresponding action of kinase is largely abolished [Quick, 1936]. Heparin thus acts as an antikinase indirectly. Its anticoagulant action is that of an antithrombin. It has been frequently suggested (originally by Howell) that heparin also acts as an antiprothrombin, and recently Brinkhous et al. [1939] have obtained direct evidence of such an antiprothrombin action. In this paper, however, only the antithrombin action of heparin will be considered. The question of the anticoagulant action of heparin is complicated by the influence of various factors outside the known clotting system. Mellanby [1934] concluded that the presence of neutral salts was necessary for the action of heparin: Howell & Holt [1918] concluded that the serum proteins, particularly the euglobulin fraction, were necessary. We have not found any evidence that salt is necessary for the action of heparin but have confirmed the work of Howell & Holt and of Quick, that the presence of serum protein is essential

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Heparin Resistance During and Post-Intravenous Nitroglycerin Infusion

      Nitroglycerin has been reported to reduce activated partial thromboplastin time (aPTT) values in patients treated with concurrent heparin and nitroglycerin. However, studies have yielded conflicting results. To determine whether intravenous nitroglycerin alters the anticoagulant effect of heparin, we prospectively evaluated twenty patients admitted for coronary angioplasty by measurin...

متن کامل

Glycosaminoglycans (GAG) from backwater clam Marcia opima (Gmelin)

Heparin was isolated from whole clam tissue Marcia opima . Purification of multimilligram quantities of heparin from this tissue sample permitted a thorough examination of its anticoagulant activity characterization, which was partially purified by fractionation by anion exchange chromatography using DEAE cellulose column. The isolated crude and partially purified fractionated sample showed me...

متن کامل

Heparin induced thrombocytopenia

Abstract Background and Objectives Heparin is still a commonly used anticoagulant in prophylaxis and treatment of thromboembolic events. Heparin-induced thrombocytopenia (HIT) is a life-threating adverse drug reaction of heparin. The diagnosis of HIT is made based on two important criteria, firstly clinical evaluation and secondly laboratory testing. In this comprehensive review, the authors w...

متن کامل

Anticoagulant synergism of heparin and activated protein C in vitro. Role of a novel anticoagulant mechanism of heparin, enhancement of inactivation of factor V by activated protein C.

Interactions between standard heparin and the physiological anticoagulant plasma protein, activated protein C (APC) were studied. The ability of heparin to prolong the activated partial thromboplastin time and the factor Xa- one-stage clotting time of normal plasma was markedly enhanced by addition of purified APC to the assays. Experiments using purified clotting factors showed that heparin en...

متن کامل

Characteristics of the hemostatic action of KFA-1411, an inhibitor of coagulation factor Xa (FXa), in humans and various animals.

This study examined a low-molecular-weight factor-Xa inhibitor, KFA-1411 (3-[N-(3-amidinophenyl)-N-[N-[4-[1-(1-iminoethyl)piperidin-4- yl]phenyl]carbamoylmethyl]aminomethyl]phenoxyacetic acid monosulfonate-dihydrate). KFA-1411 selectively inhibited FXa among the serine proteases in the human blood-coagulation cascade with a Ki value of 1.73 nM, (selectivity ratio, 15000 versus its action on thr...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • The Biochemical journal

دوره 34 2  شماره 

صفحات  -

تاریخ انتشار 1940